IFF's participation in CPhI Japan 2024 with its excipient solutions is likely to be viewed positively by investors and industry stakeholders, showcasing the company's commitment to innovation and potentially opening up new business opportunities. This could lead to increased investor confidence and a positive impact on the stock price in the short term.